I have been using Savira pharmaceuticals' products and they have been great so far. I am impressed with the quality and effectiveness. Keep up the good work!
Ask AI about Savira pharmaceuticals
AI-generated from reviews on this page. Verify anything important with the company directly.
👌 Savira pharmaceuticals is an excellent company. Their products are of top-notch quality and have been very beneficial for my health. Highly recommended!
👍 Savira pharmaceuticals is an excellent company. Their products have helped me improve my health and I am very satisfied with the results! I highly recommend them!
I have been using Savira pharmaceuticals' products for quite some time now and they have been reliable. The quality is good and they are effective. I would definitely recommend them.
I have tried some of their products and they work fine. However, I have experienced some side effects. Overall, I would say they are just average.
😊 I absolutely love Savira pharmaceuticals! Their products are excellent and have had a positive impact on my health. I highly recommend them to everyone!
Savira pharmaceuticals is an average company. I have used some of their products and they work fine. However, I have also experienced some side effects. Overall, I would say they are just average.
The products from this company are great. I have been using them for a while now and they have never disappointed me. The quality is top-notch and they are very effective.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Savira pharmaceuticals
Savira pharmaceuticals GmbH was founded in July 2009 by the European Molecular Biology Laboratory (EMBL), onepharm Research and Development GmbH, private investors, and management. Led by CEO Oliver Szolar and CSO Helmut Buschmann, a seasoned management team combines scientific, technological, and business experience in the pharmaceutical industry.
Savira follows the biotech business model, turning capital and public grants into the preclinical and clinical development of a portfolio of anti-influenza drug candidates. Savira thus strives to create a sustainable pipeline, generate value for shareholders, improve quality of life for people suffering from influenza, and add to the arsenal of antivirals thus improving influenza pandemic preparedness.
- Website
- savira.at